ApoB: The Most Important Number Your Annual Physical Never Measured

If you have had an annual physical in the last decade, you have almost certainly seen a standard lipid panel: total cholesterol, LDL-C, HDL-C, triglycerides. What you likely have not seen is apolipoprotein B, ApoB, despite a growing consensus among lipidologists that it is the single best routine measure of atherosclerotic risk.

The distinction matters because atherosclerosis is a particle problem, not a cholesterol problem. Every lipoprotein particle capable of entering the arterial wall, LDL, VLDL, IDL, Lp(a), carries exactly one ApoB molecule. Measuring ApoB therefore counts the particles doing the damage, rather than estimating the cholesterol they happen to carry.

For many people, LDL-C and ApoB tell the same story. But in a substantial minority, particularly people with insulin resistance, elevated triglycerides, or metabolic syndrome, LDL-C underestimates true particle burden. These patients carry many small, cholesterol-poor particles: the LDL-C looks acceptable while the artery wall sees a heavy particle traffic.

This discordance is not a rounding error. Discordance analyses consistently show that when LDL-C and ApoB disagree, cardiovascular risk tracks with ApoB. A patient with an LDL-C of 110 mg/dL and an ApoB in the 80th percentile is at meaningfully higher risk than their standard panel suggests.

At Nader Medical, ApoB is on every comprehensive panel, alongside a once-per-lifetime Lp(a) measurement, a genetically determined particle that affects roughly one in five people and is invisible to standard testing. We interpret both against optimal ranges informed by current evidence, not merely the population reference interval.

Prevention works when risk is measured early and treated to target. If your last physical reassured you with a normal cholesterol panel, the more precise question, and the one worth asking, is: what is your ApoB?